Business Context and Reporting Period
This Form 8-K Current Report was filed by Assembly Biosciences, Inc. on September 1, 2016. The report addresses a change in the Company's principal executive offices.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to operational updates and does not contain financial statements.
Material Changes
- Headquarters Relocation: On September 1, 2016, the Company moved its corporate headquarters to 11711 N. Meridian Street, Suite 310, Carmel, Indiana 46032.
- Contact Information: The Company's new telephone number is (317) 975-2694.
- Former Address: The previous headquarters was located at 101 Sixth Avenue, Ninth Floor, New York, NY 10013.
Outlook and Management Commentary
Management indicated that the Company expects to continue maintaining an administrative office at its former New York location for a period of time following the move. No specific financial guidance, risk factors, or contingencies were disclosed in this filing.
Investor Verification Points
- Confirm the operational status of the new Carmel, Indiana headquarters.
- Verify the timeline for the closure or reduction of the New York administrative office.
- Review subsequent filings for any financial impact related to the relocation costs.